Cancer vaccine therapy with HLA-A24 restricted epitope peptide cocktail for patients with advanced metastatic colorectal cancer. Phase I/II clinical trial.

ABSTRACT: Interventions: Subcutaneous injection of cancer vaccine (seven peptides) Primary outcome(s): Safty Immunological response (in vitro CTL induction) Study Design: Single arm Non-randomized

DISEASE(S): Advanced Metastatic Colorectal Cancers

PROVIDER: 2621744 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR